BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10660345)

  • 21. New polymorphic sites within ornithine transcarbamylase gene: population genetics studies and implications for diagnosis.
    Azevedo L; Stolnaja L; Tietzeova E; Hrebicek M; Hruba E; Vilarinho L; Amorim A; Dvorakova L
    Mol Genet Metab; 2003 Feb; 78(2):152-7. PubMed ID: 12618087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymptomatic and late-onset ornithine transcarbamylase deficiency caused by a A208T mutation: clinical, biochemical and DNA analyses in a four-generation family.
    Ausems MG; Bakker E; Berger R; Duran M; van Diggelen OP; Keulemans JL; de Valk HW; Kneppers AL; Dorland L; Eskes PF; Beemer FA; Poll-The BT; Smeitink JA
    Am J Med Genet; 1997 Jan; 68(2):236-9. PubMed ID: 9028466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and application of additional restriction fragment length polymorphisms at the human ornithine transcarbamylase locus.
    Fox JE; Hack AM; Fenton WA; Rosenberg LE
    Am J Hum Genet; 1986 Jun; 38(6):841-7. PubMed ID: 3014867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ornithine transcarbamylase deficiency: characterization of gene mutations and polymorphisms.
    Oppliger Leibundgut EO; Wermuth B; Colombo JP; Liechti-Gallati S
    Hum Mutat; 1996; 8(4):333-9. PubMed ID: 8956038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical, biochemical, and molecular spectrum of ornithine transcarbamylase deficiency.
    Tuchman M
    J Lab Clin Med; 1992 Dec; 120(6):836-50. PubMed ID: 1453106
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence for mutational cis-acting factors affecting mutagenesis in the ornithine transcarbamylase gene.
    Azevedo L; Climent C; Vilarinho L; Calafell F; Amorim A
    Hum Mutat; 2004 Sep; 24(3):273. PubMed ID: 15300856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificity of PCR-SSCP for detection of the mutant ornithine transcarbamylase (OTC) gene in patients with OTC deficiency.
    Hoshide R; Matsuura T; Komaki S; Koike E; Ueno I; Matsuda I
    J Inherit Metab Dis; 1993; 16(5):857-62. PubMed ID: 8295401
    [No Abstract]   [Full Text] [Related]  

  • 28. DNA analysis for ornithine transcarbamylase deficiency.
    Rozen R; Fox JE; Hack AM; Fenton WA; Horwich AL; Rosenberg LE
    J Inherit Metab Dis; 1986; 9 Suppl 1():49-57. PubMed ID: 2878115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allele frequencies of two polymorphisms associated with the factor IX gene in Iranian population.
    Ghandil P; Ghadiri A; Farhud D; Zeinali S
    Thromb Res; 2004; 113(5):289-93. PubMed ID: 15183040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward a molecular understanding of ornithine transcarbamylase deficiency.
    Fox JE; Rosenberg LE
    Adv Neurol; 1988; 48():71-81. PubMed ID: 2891259
    [No Abstract]   [Full Text] [Related]  

  • 31. Sex-linked inheritance of the ornithine transcarbamylase (OTC) reference anchor locus in pigs.
    Nielsen VH; Thomsen B
    Anim Genet; 1998 Apr; 29(2):152. PubMed ID: 9699282
    [No Abstract]   [Full Text] [Related]  

  • 32. Gene deletion and restriction fragment length polymorphisms at the human ornithine transcarbamylase locus.
    Rozen R; Fox J; Fenton WA; Horwich AL; Rosenberg LE
    Nature; 1985 Feb 28-Mar 6; 313(6005):815-7. PubMed ID: 2983225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Singapore Human Mutation/Polymorphism Database: a country-specific database for mutations and polymorphisms in inherited disorders and candidate gene association studies.
    Tan EC; Loh M; Chuon D; Lim YP
    Hum Mutat; 2006 Mar; 27(3):232-5. PubMed ID: 16429432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in the coding exons of the human luteinizing hormone receptor gene. Mutations in brief no. 124. Online.
    Wu SM; Jose M; Hallermeier K; Rennert OM; Chan WY
    Hum Mutat; 1998; 11(4):333-4. PubMed ID: 10215412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A strategy to discover genes that carry multi-allelic or mono-allelic risk for common diseases: a cohort allelic sums test (CAST).
    Morgenthaler S; Thilly WG
    Mutat Res; 2007 Feb; 615(1-2):28-56. PubMed ID: 17101154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of ornithine transcarbamylase gene polymorphisms with hypertension and coronary artery vasomotion.
    Dumont J; Meroufel D; Bauters C; Hansmannel F; Bensemain F; Cottel D; Hamon M; Lambert JC; Ducimetière P; Amouyel P; Zureik M; Brousseau T
    Am J Hypertens; 2009 Sep; 22(9):993-1000. PubMed ID: 19574962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haplotype analysis and phylogeny of ornithine transcarbamylase polymorphisms.
    Azevedo L; Calafell F; Vilarinho L; Amorim A
    Ann Hum Genet; 2002 Nov; 66(Pt 5-6):379-85. PubMed ID: 12516615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel complex mutation of the OTC (ornithine transcarbamylase) gene in a Malaysian pedigree.
    Khoo AS; Balraj P; Rachedi A; Chin CN; Volpi L
    Hum Mutat; 1999 Nov; 14(5):448. PubMed ID: 10533073
    [No Abstract]   [Full Text] [Related]  

  • 39. Common polymorphic OTC variants can act as genetic modifiers of enzymatic activity.
    Lopes-Marques M; Pacheco AR; Peixoto MJ; Cardoso AR; Serrano C; Amorim A; Prata MJ; Cooper DN; Azevedo L
    Hum Mutat; 2021 Aug; 42(8):978-989. PubMed ID: 34015158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mapping the silver fox genome. IV. Determination of chromosomal location of genes for ornithine carbamoyltransferase and prion protein].
    Koroleva IV; Khlebodarova TM; Rubtsov NB; Zakiian SM
    Genetika; 1994 Jun; 30(6):839-42. PubMed ID: 7958796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.